This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

COPD and Cardiovascular Risk in the Population (CORSAIB)

This study has been completed.
Fondo de Investigacion Sanitaria
Information provided by (Responsible Party):
Cimera Identifier:
First received: November 6, 2008
Last updated: June 14, 2012
Last verified: June 2012

The prevalence of chronic obstructive pulmonary disease (COPD) in patients with cardiovascular disease (CVD) is unknown, and whether or not COPD is adequately diagnosed and treated in these patients has not been investigated before.

We hypothesized that the prevalence of COPD would be significantly higher (30%) in patients with CVD than in the general population. Besides, we anticipated that COPD, a potentially treatable CV risk factor, would be undiagnosed in more than 80% of CVD patients.

Chronic Obstructive Pulmonary Disease Cardiovascular Disease

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: COPD and Cardiovascular Risk in the Population

Further study details as provided by Cimera:

Primary Outcome Measures:
  • Prevalence of COPD defined according to the current GOLD guidelines as a post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) <0.7. [ Time Frame: Current ]

Secondary Outcome Measures:
  • Underdiagnosis of COPD [ Time Frame: Current ]
  • Undertreatment of COPD [ Time Frame: Current ]

Biospecimen Retention:   Samples Without DNA
Samples of serum were frozen at -80 ºC

Enrollment: 623
Study Start Date: October 2006
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Detailed Description:

We aim to compare clinical and spirometric data in three groups of individuals. Two of them are participants in an ongoing population-based study (CORSAIB) aimed at investigating the distribution of CVD risk factors in the general population of the Balearic Islands, Spain. The design and full methodological details of the CORSAIB study have been published elsewhere (Rigo F, et al. Rev Clin Espa 2005). A third group will include patients with stable CVD regularly visited at the referral hospital of our community.

Inclusion criteria for the study are male and female individuals, aged 40 to 81 years, residents of the Balearic Islands, and who are willing to participate in this research.


Ages Eligible for Study:   40 Years to 81 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Random population sample, and a sample of hospital cardiovascular patients

Inclusion Criteria:

  • residents of the Balearic Islands
  • willing to participate in this research
  • able to sign the written consent form

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00787748

Bunola, Illes Balears, Spain, 07110
Sponsors and Collaborators
Fondo de Investigacion Sanitaria
Study Director: Fernando Rigo, MD Atención Primaria de Mallorca
Study Director: Alvar Agusti, MD Cimera
  More Information

Additional Information:
Responsible Party: Cimera Identifier: NCT00787748     History of Changes
Other Study ID Numbers: PI061228
Study First Received: November 6, 2008
Last Updated: June 14, 2012

Keywords provided by Cimera:

Additional relevant MeSH terms:
Lung Diseases
Cardiovascular Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases processed this record on August 16, 2017